Cartesian Therapeutics shares are trading lower. The company announced approval of conversion of Series A Convertible Preferred Stock and plans to effect a reverse stock split.

Cartesian Therapeutics, Inc. - Common Stock +0.34%

Cartesian Therapeutics, Inc. - Common Stock

RNAC

26.43

+0.34%

Cartesian Therapeutics shares are trading lower. The company announced approval of conversion of Series A Convertible Preferred Stock and plans to effect a reverse stock split.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via